Skip to main content Skip to main navigation menu Skip to site footer
MedNext Journal of Medical and Health Sciences
Review
DOI: 10.54448/mdnt22S104
Submitted: 04-04-2022
Published: 04-04-2022

Platelet-rich plasma and bone morphogenetic protein: bucomaxillofacial and bone regeneration

ECUDENT CLINIC, Quito, Ecuador; UNORP - University Center North Paulista - Sao Jose do Rio Preto, Sao Paulo, Brazil; UNIPOS - Post graduate and continuing education, Sao Jose do Rio Preto, Sao Paulo, Brazil
ECUADENT CLINIC, Quito, Ecuador; UNORP - University Center North Paulista - Sao Jose do Rio Preto, Sao Paulo, Brazil; UNIPOS - Post graduate and continuing education, Sao Jose do Rio Preto, Sao Paulo, Brazil
UNORP - University Center North Paulista - Sao Jose do Rio Preto, Sao Paulo, Brazil; UNIPOS - Post graduate and continuing education, Sao Jose do Rio Preto, Sao Paulo, Brazil
Bone regeneration Bone Remodelation Platelet-rich plasma Bone morphogenetic protein

Abstract

Introduction: Science has evolved at an accelerated pace in the last decades, due to the need to know more and more the human being and the environment that surrounds them. In the search for this knowledge, aiming to improve the quality of life and the treatment of diseases previously considered incurable, research, especially in the field of biotechnology, has transformed the day-to-day health professionals. The application of this biotechnology related to growth factors can be exemplified in the use of platelet-rich plasma (PRP), gel capable of modulating and accelerating some repair processes. Objective: The objective of this work was to review the concepts related to growth factors, as well as in relation to platelet-rich plasma as an adjuvant in bone regeneration therapies. Methods: The present study followed a systematic review model, following the rules of systematic review – PRISMA. This study focuses on the treatment of bone regeneration through platelet-rich plasma and morphogenetic protein (BMP). To this end, a survey was conducted in scientific articles in the databases PubMed, Medline, Scielo, Lilacs, and e-books. The Cochrane Instrument was used to assess the risk of bias of the included studies, and GRADE was used to classify the quality of articles to the type of study and scientific evidence. Results and Conclusion: Therefore, the use of PRP, which would accelerate the rate of bone formation, with bone morphogenetic proteins (BMPs), recombinant or autogenous, should be quite important and elucidative. The development of new research, seeking to use all known technology, will always be the best way for a short future to recognize what should be incorporated into the daily routine of medical and dental clinics, differing from what, for various reasons, whether it was just a marketing procedure or something. The greatest advantage of the use of platelet-rich plasma is its ability to accelerate the process of bone regeneration by increasing the number of growth factors present in human platelets. On the other hand, it is observed that one of its major disadvantages is the low life expectancy of these platelets in the recipient or graft bed. However, it is also known that the PRP technique would only accelerate a process of bone regeneration that normally already occurs and this process follows its path until the formation of the mature bone.

Metrics

Metrics Loading ...

References

  1. Cicciù M, Fiorillo L, Cervino G, Habal MB. Bone Morophogenetic Protein Application as Grafting Materials for Bone Regeneration in Craniofacial Surgery: Current Application and Future Directions. J Craniofac Surg. 2021 Mar-Apr 01;32(2):787-793. doi: 10.1097/SCS.0000000000006937. PMID: 33705037.
  2. Kargarpour Z, Nasirzade J, Panahipour L, Mitulović G, Miron RJ, Gruber R. Platelet-Rich Fibrin Increases BMP2 Expression in Oral Fibroblasts via Activation of TGF-β Signaling. Int J Mol Sci. 2021 Jul 25;22(15):7935. doi: 10.3390/ijms22157935. PMID: 34360701; PMCID: PMC8347014.
  3. Dissaux C, Ruffenach L, Bruant-Rodier C, George D, Bodin F, Rémond Y. Cleft Alveolar Bone Graft Materials: Literature Review. Cleft Palate Craniofac J. 2021 Apr 7:10556656211007692. doi: 10.1177/10556656211007692. Epub ahead of print. PMID: 33823625.
  4. Caballé-Serrano J, Sawada K, Miron RJ, Bosshardt DD, Buser D, Gruber R. Collagen barrier membranes adsorb growth factors liberated from autogenous bone chips. Clin Oral Implants Res. 2016 Jan 28.
  5. Mazaro JVQ, Godoy PAI, Junior JFS, Mello CC, Pellizzer EP, ZavanelliAC; Regeneração óssea guiada em implantodontia: relato de caso; RFO, Passo Fundo, v. 19, n. 1, p. 121-128, jan./abr. 2014.
  6. Fernandes TBG. Utilização de membranas absorvíveis e não absorvíveis em técnicas de regeneração óssea na implantodontia; Uberlândia, 2015.
  7. Costa JBZ, Silva F, Dultra CA, Souza LF, Santos MCNE; Uso de membranas biológicas para regeneração óssea guiada em implantodontia – uma revisão de literatura - Revista Bahiana de Odontologia. 2016 Mar;7(1):14-21.
  8. Saghiri MA, Asatourian A, Garcia-Godoy F, Sheibani N. The role of angiogenesis in implant dentistry part II: The effect of bone-grafting and barrier membrane materials on angiogenesis. Med Oral Patol Oral Cir Bucal. (2016), doi:10.4317/medoral.21200.
  9. Tejero, R., Anitua, E. eOrive, G. (2014). Toward the biomimetic implant surface: Biopolymers on titanium-based implants for bone regeneration. Journal of Progress in Polimeral Science, 39, pp. 1406-1447.
  10. Merli M, Merli I, Raffaelli E, Pagliaro U, Nastri L, Nieri M. Bone augmentation at implant dehiscences and fenestrations. A systematic review of randomised controlled trials. Eur J Oral Implantol. 2016 Spring;9(1):11-32.
  11. Anitua E. Plasma rich in growth factors: preliminary results of use in the preparation of future sites for implants. The Int. J. Oral & Maxillofacial Implants. v.14, n.4, p.529-35, 1999.
  12. Becker P., Lynch SE., Leckholm V., Cafesse R., Donath K., Sanches R. A comparison of PTFE membranes alone or in combination with platelet-derived promoting bone formation around immediate extraction socket implants. J. Periodontology. V.63, n.11, p.929-40, 1992.
  13. Body S.C. Platelet activation and interactions with the microsvaculature. J. of Cardiovascular Pharmacology. V.27, p.13-25, 1996.
  14. Canalis E., Centrella M., Busch W., McCarthy T.L. Insulin-like growth factor I mediates selective anabolic effects of parathyroid hormone in bone cultures. J. Clin. Invest.v.83, p.60-65,1989.
  15. Caplan A.I..Mesenquimal stem cells. J. Orthop. Res. Vol.9, n.5, p.641-50,1991
  16. Cochran D.L. & Wozney J.M. Biological mediators for periodontal regeneration. Periodontology 2000, v.19, p.40-58,1999.
  17. Cook S. D., Salked S.L. Rueger D.C. Evaluation of recombinant human osteogenic protein-1 (rh OP-1) placed with dental implants in fresh extraction sites. J. Oral Implantol. v. 21, p.281-289, 1995.
  18. Giannobile W.V., Finkelman R.D., Lynch S.E. Comparison of canine and non-human primate models for periodontal regenerative therapy: results following a single administration of PDGF/IGF-I. J. Periodontology. v.65, n.12, p.1158-68, 1994.
  19. Gil J.N., Gasperini G., Manfro R., Marin C. Emprego de plasma rico em plaquetas na reconstrução de fendas alveolares- apresentação de caso clinico. BCI -Rev. Bras. de Cir. e Implantod. V.9, n. 35, 2002.
  20. Graves D.T., Opran A.V., Delgado R., Valente A.J., Mundy G., Piche J. The potential role of platelet-derived growth factor as an autocrine or paracrine factor for human bone cells. Connect. Tissue res.v.23. p. 209-18, 1989.
  21. Hiraki Y., Inoue H., Hirai R.,Kato Y., Suzuki F. Effect of transforming growth factor β on cell proliferation and glycosaminoglycan synthesis by rabbit growth-plate chondrocytes in culture. Biochim. Biophys Acta . v.969, n.1,p.91-9, 1988.
  22. Kinghton D.R., Ciresi K.F., Schunoth V.D., Butler S., Cerra E. Stimulation of repair in chronic non-healing cutaneous ulcers using platelet-derived wound healing formula. Surg. Gynecol. Obstet. v.170, p.56, 1990.
  23. Kose K., Xie J., Carnes D., Graves D. Pro-inflammatory cytokines downregulate platelet derived growth factor-α receptor gene expression in human osteoblastic cells. J. Cell. Physiol. V.166, n.1, p.188-97, 1996.
  24. Lee Y., Park Y., Seung J.L., Young K., Soo-Boo H., Perry R.K., Chong-Pyoung C. The bone regenerative effect of platelet-derived growth factor –BB delivered with a Chitosan/ tricalcium phosphate sponge carrier. J. Periodontol. v.71, n.3. p.418-424, 2000.
  25. Lenharo A., Cosso F. Fatores de crescimento: quando utilizar? 3i Innovations J. v.5, n.1, 2001.
  26. Lind M. Growth factor stimulation of bone healing. Effects on osteoblasts, osteotomies and implants fixation. Acta Orthop. Scand. Suppl. v.283, p.2-37, 1998.
  27. Lozada J.L., Caplanis N., Proussaefs P., Willardsen J., KAMMEYER G. Platelet-rich plasma application in sinus graft surgery: part I- background and processing techniques. J.Oral Implantol. V.27, n.1,2001.
  28. Lynch S.E, De Castilla E.R., Williams R.C. The effects of shortterm application of platelet-derived and insulin-like growth factors on periodontal wound healing. J. Periodontology. v. 62, p.458-67, 1991.
  29. Lynch S.E., Buser D., Hernandez R.A., Weber H.P., Stich H., Fox C.H., Williams R.C. Effects of the platelet-derived growth factor/insulin-like growth factor I combination on bone regeneration around titanium dental implants- results of a pilot study in beagle dogs. J.Periodontology. v.62, p.710-16, 1991.
  30. Lynch S.E., Williams R.C., Polson A.M., Howell T.H., Reddy M.S., Zappa U.E., Antoniades H.N. A combination of platelet-derived and insulin-like growth factors enhances periodontal regeneration. J. Clinical Periodontol. v. 16, p.545-48, 1989.
  31. Marx R.E., Carlson E.R., Eischstaedt R.M., Shimmele S.R., STRAUSS J.E., GEORGEFF K.R. Platelet-rich plasma: growth factor enhancement for bone grafts. Oral Surg. Oral Med. Oral Pathol. v.85, p.683-46, 1998.
  32. Marx R.E.Platelet-rich plasma: a source of multiple autologous growth factors for bone grafts. In: LYNCH S.E., GENCO R.J., MARX R.E. Tissue engineering. Illinois: Quintessence,1999. p.71-82.
  33. Marx R.E.Platelets concentrate: a strategy for accelerating and improving bone regeneration. In: DAVIES J.E. Bone engineering. Toronto: em squared incorporated,2000. p.447-53.
  34. Matsuda N., Lin W.L. Kumar N.M., Cho M.I., Genco R.J. Mitogenical chemotactic and synthetic responses of rat periodontal ligament fibroblastic cells to polypeptide growth factors in vitro. J. Periodontology. v. 63, n.6, p.515-25, 1992.
  35. Mohan S., Baylink D. J. Bone growth factors. Clin. Orthop. Relt. Res. V.263, p.30-43, 1991.
  36. Obarrio J.J., Arauz-Dutari J.,Chamberlain T.M., Croston A. The use of autologous growth factors in periodontal surgical therapy: platelet-derived gel biotechnology- case reports. The Int. J. of Periodont. & Restorat. Dentist. v. 20, n.5, p.486-497, 2000.
  37. Park J., Davies J.E. Interações de hemácias e plaquetas com superfícies de implante de titânio. 3i Innovations J. v.5, n.2, p.26-34,2001.
  38. Rossi Jr, Lemos J.J., Pispico R. Utilização de plasma rico em plaquetas em enxertos ósseos- proposta de um protocolo de obtenção simplificado. [ on line ] . 2001 [ citado 2001-05-05 ] . Disponível na Word Wide Web: htpp: //www.periodesktop.hpg.com.br/artigos/a12.htm.
  39. Rutherford R.B., Ryan M.E., Kennedy J.E., Charette M.F., Tucker M.M. Platelet-derived growth factor and dexamethazona combined with a collagen matrix induce regeneration of the periodontium in monkeys. J. Clin. Periodontol. v.20, n. 7, p.537-44, 1993.
  40. Rutherford R.B., Sampath T.K., Rueger D.C. Use of bovine osteogenic protein to promote rapid osseointegration of endosseous dental implants. Int. J. Oral Maxillofac. Implants. v. 7, p. 297-31, 1992.
  41. Sonnleitner D., Huemer P., Sullivan D.Y. Asimplifield technique for producing platelet-rich plasma and platelet concentrate for intraoral bone grafting techniques: a technical note. Int. J. Oral Maxillofac. Implants. v. 15, p.879-82, 2000.
  42. Sporn M.B. & Roberts A.B. J Clin. Invest. Vol.78, p.329-32, 1986.
  43. Stefani C.M., Machado M.A.N., Sallum E.A., Sallum A.W., Toledo S., Nociti Jr. F.H. Platelet-derived growth factor/insulin-like growth factor-1 combination and bone regeneration around implants placed into extraction sockets: a histometric study in dogs. Implant Dentistry. v.9, n.2, p.126-31, 2000.
  44. Stephan E.B., Renjen R., Lynch S.E., Dziak R. Platelet-derived growth factor enhancement of a mineral- collagen bone substitute. J. Periodontol. v. 71, n.12, p. 1887-92, 2000.
  45. Tayapongsak P., O’Brien D.A., Monteiro C.B., Arceo-Diaz L.L. Autologous fibrin adhesive in mandibular reconstruction with particulate cancellous bone and narrow. J. Oral Maxillofac. Surg. v. 52, p.161-66, 1994.
  46. Vikjaer D., Blom S., Hjorting-Hansen E., Pinholt E.M., Effect of platelet-derived growth factor- BB on bone formationin calvarial defects: an experimental study in rabbits. Eur. J. Oral. Sci. v.105, n.1, p.59-66, 1997.
  47. Whitman D.H., Berry R.L., Green D.M. Platelet gel: an autolgous alternative to fibrin glue with applications in oral and maxillofacial surgery. J. Oral Surg. v. 55, p.1294-99, 1977.
  48. Yeh Y., Kang Y., Chaibi M., Xie J., Graves D. IL-1 and transforming growth factor-β inhibit platelet-derived growth factor- AA binding to osteoblastic cells by reducing platelet-derived growth factor-α receptor expression. J.Immunol. v.15, n.150, p.5625-32, 1993.

How to Cite

Yaguana Galarraga, D. A., Romero Urdiales, L. A., & Manzini, R. (2022). Platelet-rich plasma and bone morphogenetic protein: bucomaxillofacial and bone regeneration. MedNEXT Journal of Medical and Health Sciences, 3(S1). https://doi.org/10.54448/mdnt22S104